{"id":405031,"date":"2019-07-03T11:16:01","date_gmt":"2019-07-03T11:16:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=405031"},"modified":"2019-07-03T11:16:01","modified_gmt":"2019-07-03T11:16:01","slug":"liquid-biopsy-market-study-with-competitive-landscape-market-insights-and-growth-prospects-to-2024-biocept-qiagen-roche-diagnostics-biorad-lab-trovagene","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/liquid-biopsy-market-study-with-competitive-landscape-market-insights-and-growth-prospects-to-2024-biocept-qiagen-roche-diagnostics-biorad-lab-trovagene_405031.html","title":{"rendered":"Liquid Biopsy Market Study with Competitive Landscape, Market Insights and growth Prospects to 2024| Biocept, Qiagen, Roche Diagnostics, Bio-Rad Lab, Trovagene"},"content":{"rendered":"
Liquid Biopsy Comprehensive Study by Type (Assays Kits, Instruments, Services), Application (Oncology (Lung Cancer. Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer and Other Cancer), Non-Cancer Application), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics), Circulating Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) Players and Region – Global Market Outlook to 2024<\/div>\n

AMA recently added a comprehensive study of over 200+ pages in its publication on ‘Liquid Biopsy’ market  with historical & forecast data from 2013-2025. The study provides market size break-up by revenue and volume* for potential countries and important business segments. List of some players from a wide list of coverage used under bottom-up approach are Biocept Inc. (United States), Qiagen N.V. (Netherlands), Roche Diagnostics (Switzerland), Bio-Rad Laboratories Inc. (United States), Myriad Genetics Inc (United States), Menarini-Silicon Biosystems (Italy), Trovagene Inc. (United States), Guardant Health Inc. (United States), Mdxhealth SA (Belgium), Genomic Health Inc. (United States).<\/p>\n

A liquid biopsy is used to help find cancer at early stage, using sample of blood of tumor circulating within blood or pieces of DNA of the tumor. It is non-invasive alternative to surgical biopsy. Rapid advancement in the liquid biopsy for enhancing the safety of cancer patients and for providing ease to the doctors during critical operations is expected to boost the growth opportunities for manufacturers of the liquid biopsy.<\/p>\n

Request a sample report @ https:\/\/www.advancemarketanalytics.com\/sample-report\/33048-global-liquid-biopsy-market<\/a><\/p>\n

Market Segmentation<\/p>\n

by  Type (Assays Kits, Instruments, Services), Application (Oncology (Lung Cancer. Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer and Other Cancer), Non-Cancer Application), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics), Circulating Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Cell-Free DNA (cfDNA), Extracellular Vesicles (EVs), Other Circulating Biomarkers), End-User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers, Other)<\/p>\n

Make an enquiry before buying this Report @ https:\/\/www.advancemarketanalytics.com\/enquiry-before-buy\/33048-global-liquid-biopsy-market<\/a><\/p>\n

What’s Trending in Market: Favorable government initiatives, and presence of huge cancer population base<\/p>\n

Rapid technological advancement in the liquid biopsy<\/p>\n

Growth Drivers: Surging incidences of lung cancer, gastrointestinal cancer, and breast cancer<\/p>\n

Increasing inclination of physician and oncologists to opt for diagnostic with non-invasive procedures<\/p>\n

Restraints: Higher cost associated with liquid biopsy compared to conventional techniques<\/p>\n

View Detailed Table of Content @ https:\/\/www.advancemarketanalytics.com\/reports\/33048-global-liquid-biopsy-market<\/a><\/p>\n

Country level Break-up includes:<\/p>\n

North America (United States, Canada and Mexico)<\/p>\n

Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)<\/p>\n

Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)<\/p>\n

Table of Contents<\/p>\n

Global Liquid Biopsy Market Research Report<\/p>\n

Chapter 1 Global Liquid Biopsy Market Overview<\/p>\n

Chapter 2 Global Economic Impact on Industry<\/p>\n

Chapter 3 Global Market Competition by Manufacturers<\/p>\n

Chapter 4 Global Productions, Revenue (Value) by Region<\/p>\n

Chapter 5 Global Supplies (Production), Consumption, Export, Import by Regions<\/p>\n

Chapter 6 Global Productions, Revenue (Value), Price Trend by Type<\/p>\n

Chapter 7 Global Market Analysis by Application<\/p>\n

Chapter 8 Manufacturing Cost Analysis<\/p>\n

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers<\/p>\n

Chapter 10 Marketing Strategy Analysis, Distributors\/Traders<\/p>\n

Chapter 11 Market Effect Factors Analysis<\/p>\n

Chapter 12 Global Liquid Biopsy Market Forecast<\/p>\n

Buy this report @ https:\/\/www.advancemarketanalytics.com\/buy-now?format=1&report=33048<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> AMA Research & Media LLP<\/a>
Contact Person:<\/strong> Craig Francis
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 (206) 317 1218
Address:<\/strong>Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837
City:<\/strong> New Jersey
State:<\/strong> New Jersey
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.advancemarketanalytics.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Liquid Biopsy Comprehensive Study by Type (Assays Kits, Instruments, Services), Application (Oncology (Lung Cancer. Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer and Other Cancer), Non-Cancer Application), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics), Circulating … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406],"tags":[],"class_list":["post-405031","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/405031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=405031"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/405031\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=405031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=405031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=405031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}